RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
HAEMATOLOGICA
Collezione AOU San Luigi di Orbassano

Items : 17

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638.

2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Candoni A; Foa R; Ferrara F; Pizzolo G; Bassan R; Starza ID; Fanin R; Luppi M; Marsili G; Vignetti M; Piciocchi A; Mancini V; De Bellis E; Trastulli F; Ciccone M; De Gobbi M; Cignetti A; Mazzone C; Aprile L; Mauro E; Fanin M; Chiusolo P; Minetto P; Defina M; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; et alii...

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry. in Haematologica / Haematologica. 2024 Aug 1;109(8):2693-2700. doi: 10.3324/haematol.2023.284678.

2024
AOU Alessandria
AOU San Luigi di Orbassano

Prin R; Wolf D; Arellano E; Ammatuna E; Nordlander A; Cabirta A; Cordoba R; Garcia-Bordallo D; Tragiannidis A; Rodrigues RN; Vehreschild M; Ra?il Z; Hanakova M; Lievin R; Mitrovic M; Garcia-Sanz R; Cvetanoski M; Varricchio G; Bahr NC; Emarah Z; De Ramon C; Meers S; Di Blasi R; Mendez GA; Pantic N; Stojanoski Z; Erben N; Groh A; Cattaneo C; et alii...

Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting. in Haematologica / Haematologica. 2023 Apr 1;108(4):1158-1162. doi: 10.3324/haematol.2022.280815.

2023
AOU San Luigi di Orbassano

Pinto VM; Gianesin B; Piel FB; Longo F; Rigano P; Quota A; Spadola V; Graziadei G; Mazzi F; Cappellini MD; Maggio A; Piga A; De Franceschi L; Forni GL;

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Soverini S; Albano F; Simula MP; Sorà F; Porretto F; Cavazzini F; Cedrone M; Trabacchi E; Bocchia M; Martino B; Tiribelli M; Rege-Cambrin G; Stagno F; D'Adda M; Salvucci M; Intermesoli T; Levato L; Breccia M; Castagnetti F; Gugliotta G; Foà R; Pane F; Cavo M; Saglio G; Baccarani M; Rosti G;

Tricuspid-valve regurgitant jet velocity as a risk factor for death in ?-thalassemia. in Haematologica / Haematologica. 2022 Jul 1;107(7):1714-1718. doi: 10.3324/haematol.2021.280389.

2022
AOU San Luigi di Orbassano

Derchi G; Musallam KM; Pinto VM; Graziadei G; Giuditta M; Barella S; Origa R; Casu G; Pasanisi A; Longo F; Casale M; Miceli R; Merella P; Gianesin B; Ameri P; Tartaglione I; Perrotta S; Piga A; Cappellini MD; Forni GL;

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial. in Haematologica / Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2019
AOU Alessandria
AOU San Luigi di Orbassano

Mantoan B; Gueli A; Billio A; Angrilli F; Perrone T; Lanza F; Semenzato G; Parvis G; Dondi A; Narni F; Zallio F; Zoli V; Devizzi L; Tucci A; Di Raimondo F; Stelitano C; Rota-Scalabrini D; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; Pulsoni A; Barbui AM; Patti C; Boccomini C; Benedetti F; Bruna R; et alii...

Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia. in Haematologica / Haematologica. 2017 Sep;102(9):1530-1536. doi: 10.3324/haematol.2017.169532. Epub 2017 Jun 1.

2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Martinelli G; Cavo M; Foà R; Soverini S; Caracciolo C; Bonifacio M; Binotto G; Bigazzi C; Tiribelli M; Sorà F; La Barba G; Martino B; Stagno F; Cavazzini F; D'Adda M; Pregno P; Levato L; Intermesoli T; Abruzzese E; Albano F; Iurlo A; Breccia M; Castagnetti F; Gugliotta G; Pane F; Saglio G; Baccarani M; Rosti G; Gugliotta G; et alii...

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients. in Haematologica / Haematologica. 2016 Oct;101(10):1200-1207. doi: 10.3324/haematol.2016.144949. Epub 2016 Jul 28.

2016
AOU San Luigi di Orbassano

Castagnetti F; Breccia M; Gugliotta G; Martino B; D'Adda M; Stagno F; Carella AM; Avanzini P; Tiribelli M; Trabacchi E; Visani G; Gobbi M; Salvucci M; Levato L; Binotto G; Capalbo SF; Bochicchio MT; Soverini S; Cavo M; Martinelli G; Alimena G; Pane F; Saglio G; Rosti G; Baccarani M;

Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia. in Haematologica / Haematologica. 2015 Sep;100(9):1146-50. doi: 10.3324/haematol.2015.129221. Epub 2015 Jun 25.

2015
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Levato L; D'Adda M; Stagno F; Tiribelli M; Salvucci M; Fava C; Martino B; Cedrone M; Bocchia M; Trabacchi E; Cavazzini F; Usala E; Russo Rossi A; Bochicchio MT; Soverini S; Alimena G; Cavo M; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G;

Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging. in Haematologica / Haematologica. 2010 Aug;95(8):1308-16. doi: 10.3324/haematol.2009.016824. Epub 2010 Jun 9.

2010
AOU San Luigi di Orbassano

Messa E; Carturan S; Maffè C; Pautasso M; Bracco E; Roetto A; Messa F; Arruga F; Defilippi I; Rosso V; Zanone C; Rotolo A; Greco E; Pellegrino RM; Alberti D; Saglio G; Cilloni D;

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy. in Haematologica / Haematologica. 2008 Jun;93(6):921-4. doi: 10.3324/haematol.12165. Epub 2008 Apr 28.

2008
AOU San Luigi di Orbassano

Cilloni D; Messa F; Arruga F; Defilippi I; Gottardi E; Fava M; Carturan S; Catalano R; Bracco E; Messa E; Nicoli P; Diverio D; Sanz MA; Martinelli G; Lo-Coco F; Saglio G;

Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. in Haematologica / Haematologica. 2005 Sep;90(9):1161-7.

2005
AOU San Luigi di Orbassano

Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A;

Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. in Haematologica / Haematologica. 2002 Oct;87(10):1014-20.

2002
AOU San Luigi di Orbassano

Giugliano E; Rege-Cambrin G; Scaravaglio P; Wlodarska I; Emanuel B; Stul M; Serra A; Tonso A; Pini M; Saglio G; Hagemeijer A;

Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome. in Haematologica / Haematologica. 1999 Jun;84(6):489-92.

1999
AOU San Luigi di Orbassano

Cicilano M; Zecchina G; Roetto A; Bosio S; Infelise V; Stefani S; Mazza U; Camaschella C;

Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis. in Haematologica / Haematologica. 1997 Sep-Oct;82(5):592-3.

1997
AOU San Luigi di Orbassano

Sivera P; Roetto A; Mazza U; Camaschella C;

Hereditary hemochromatosis: recent advances in molecular genetics and clinical management. in Haematologica / Haematologica. 1997 Jan-Feb;82(1):77-84.

1997
AOU San Luigi di Orbassano

Camaschella C; Piperno A;

Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective. in Haematologica / Haematologica. 1995 Sep-Oct;80(5):454-72.

1995
AOU San Luigi di Orbassano

Gaidano G; Pastore C; Volpe G;